JAMA Neurology

10/07/2025

In patients with post-dural puncture headache who do not respond to conventional treatment, iatrogenic CSF-venous fistula should be considered as it may necessitate different treatment. https://ja.ma/3IW54F3

10/06/2025

Brain arteriovenous malformations, also known as AVMs, are high flow cerebrovascular lesions with great potential to cause intracranial hemorrhage and epilepsy.

In this podcast episode, author Helen Kim, PhD, discusses management of patients with brain arterial venous malformations with JAMA Neurology Web Editor Cynthia Armand.

Listen now:

Interview with Helen Kim, PhD, author of Risk of Future Hemorrhage From Unruptured Brain Arteriovenous Malformations: The Multicenter Arteriovenous Malformation Research Study (MARS). Hosted by Cynthia E. Armand, MD.

10/06/2025

The annual rate of first intracranial hemorrhage from unruptured brain AVMs was 1.4% in a multinational cohort, lower than commonly cited estimates.

https://ja.ma/3Ix6aHr

10/06/2025

Editorial: The ATIS-NVAF trial shows adding antiplatelet therapy to OAC in stroke patients with AF and atherosclerotic disease increases major bleeding without significant reduction in ischemic events.

https://ja.ma/46NHJ1L

10/06/2025

In patients with ischemic stroke and concurrent nonvalvular atrial fibrillation and ASCVD, adding an antiplatelet agent to anticoagulant therapy offered no net clinical benefit over anticoagulant monotherapy.

https://ja.ma/4ocl2dr

10/04/2025

The VasCog-2-WSO criteria provide updated international guidelines for diagnosing vascular cognitive impairment and , incorporating recent biomarker advancements. https://ja.ma/3IUrW7V

10/02/2025

Case report: brain imaging of 2 patients with a disease course suggestive of autoimmune glial fibrillary acidic protein astrocytopathy. https://ja.ma/4pOq5lE

10/01/2025

Case report: an atypical postvaccinal encephalitis in a 60-year-old man, with radial perivascular enhancement consistent with inflammation of glial fibrillary acidic protein–rich white matter loci.

This case report describes an atypical postvaccinal encephalitis in a 60-year-old man, with radial perivascular enhancement consistent with inflammation of glial fibrillary acidic protein–rich white matter loci.

09/29/2025

Case report: a patient with X-linked FHL1-related myofibrillar myopathy and Charcot-Marie-Tooth disease type 1A, a dual pathology revealed by imaging and genetic testing. https://ja.ma/42d8vha

09/29/2025

"The book is not closed on a more expansive view of the entire menopausal transition."

Learn more in this Editorial. https://ja.ma/46ASZNn

09/29/2025

In this study, menopause was not the primary driver of multiple sclerosis clinical progression in women at midlife. https://ja.ma/4mvxm73

09/27/2025

OTOF gene therapy (GT) offers rapid improvements in auditory and speech performance, outperforming cochlear implantation (CI) in speech in noise and music perception.

https://ja.ma/3KH8092